These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3346570)

  • 1. Markers of cell-mediated immunity after vaccination with an inactivated, whole-cell Q fever vaccine.
    Izzo AA; Marmion BP; Worswick DA
    J Infect Dis; 1988 Apr; 157(4):781-9. PubMed ID: 3346570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs.
    Marmion BP; Ormsbee RA; Kyrkou M; Wright J; Worswick DA; Izzo AA; Esterman A; Feery B; Shapiro RA
    Epidemiol Infect; 1990 Apr; 104(2):275-87. PubMed ID: 2323360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine prophylaxis of abattoir-associated Q fever.
    Marmion BP; Ormsbee RA; Kyrkou M; Wright J; Worswick D; Cameron S; Esterman A; Feery B; Collins W
    Lancet; 1984 Dec; 2(8417-8418):1411-4. PubMed ID: 6151039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited humoral and cellular responses to Q fever vaccination in older adults with risk factors for chronic Q fever.
    Schoffelen T; Herremans T; Sprong T; Nabuurs-Franssen M; Wever PC; Joosten LA; Netea MG; van der Meer JW; Bijlmer HA; van Deuren M
    J Infect; 2013 Dec; 67(6):565-73. PubMed ID: 23973626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term immune responses to Coxiella burnetii after vaccination.
    Kersh GJ; Fitzpatrick KA; Self JS; Biggerstaff BJ; Massung RF
    Clin Vaccine Immunol; 2013 Feb; 20(2):129-33. PubMed ID: 23192629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immune response to Coxiella burnetii antigens in Q fever convalescents and vaccinees.
    Gajdosová E; Brezina R
    Acta Virol; 1989 Sep; 33(5):474-81. PubMed ID: 2576587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.
    Chen C; van Schaik EJ; Gregory AE; Vigil A; Felgner PL; Hendrix LR; Faris R; Samuel JE
    J Infect Dis; 2019 Jul; 220(4):624-634. PubMed ID: 30938819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens.
    Izzo AA; Marmion BP; Hackstadt T
    Clin Exp Immunol; 1991 Jul; 85(1):98-108. PubMed ID: 2070564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines against Coxiella infection.
    Zhang G; Samuel JE
    Expert Rev Vaccines; 2004 Oct; 3(5):577-84. PubMed ID: 15485337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of skin test in Q fever convalescents and vaccinees as indicator of antigen exposure and inducer of antibody recall.
    Kazár J; Schramek S; Brezina R
    Acta Virol; 1984 Mar; 28(2):134-40. PubMed ID: 6145346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Components of protective immunity.
    Zhang G; Zhang Y; Samuel JE
    Adv Exp Med Biol; 2012; 984():91-104. PubMed ID: 22711628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990.
    Ackland JR; Worswick DA; Marmion BP
    Med J Aust; 1994 Jun; 160(11):704-8. PubMed ID: 8202006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine.
    Kishimoto RA; Johnson JW; Kenyon RH; Ascher MS; Larson EW; Pedersen CE
    Infect Immun; 1978 Jan; 19(1):194-8. PubMed ID: 624586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice.
    Williams JC; Damrow TA; Waag DM; Amano K
    Infect Immun; 1986 Mar; 51(3):851-8. PubMed ID: 3949384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever.
    Fries LF; Waag DM; Williams JC
    Infect Immun; 1993 Apr; 61(4):1251-8. PubMed ID: 8454328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity in Q fever.
    Kazár J
    Acta Virol; 1988 Jul; 32(4):358-68. PubMed ID: 2903642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of immunoglobulin G (IgG) and A (IgA) subclasses following Q fever vaccination with soluble phase I Coxiella burnetii extract.
    Camacho MT; Outschoorn I; Kovácová E; Téllez A
    Vaccine; 2000 Mar; 18(17):1773-7. PubMed ID: 10699325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled, double-blind, cross-over, clinical trial of Q fever vaccine in selected Queensland abattoirs.
    Shapiro RA; Siskind V; Schofield FD; Stallman N; Worswick DA; Marmion BP
    Epidemiol Infect; 1990 Apr; 104(2):267-73. PubMed ID: 2182329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Q-fever soluble vaccine effects in Coxiella burneti sensitized humans.
    Crăcea E; Dumitrescu-Constantinescu S; Botez D; Ioanid L
    Zentralbl Bakteriol Orig A; 1977 Jul; 238(3):413-8. PubMed ID: 910580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suitability of the microagglutination test for detection of post-infection and post-vaccination Q fever antibodies in human sera.
    Kazár J; Brezina R; Schramek S; Palanová A; Tvrdá B
    Acta Virol; 1981 Jul; 25(4):235-40. PubMed ID: 6116418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.